Good morning! It has been a hectic week for results, but we're expecting a quieter day today. Today's Agenda is now complete - and the report is now finished. Have a great weekend.

New Data Insights Article: please make sure you check out the Smart Money Playbook, which has just been published by Stockopedia:

In our latest deep dive, we’ve analysed a database of over 105,000 director deals, explored patterns in analyst recommendations, and assessed the investment habits of top-performing fund managers. The result? A data-driven guide to spotting and leveraging smart money movements—allowing you to make more strategic, confident investment choices.

Companies Reporting

Name (Mkt Cap)RNSSummaryOur view (Author)

Berkeley group (LON:BKG) (£3.3bn)

Trading Statement

Reaffirms earnings guidance - at least £975m of PBT across FY25 (£525m) and FY26 (£450m)

AMBER (Graham) [no section below]
Profit guidance is impressive and puts the shares on a PER of about 10x for FY April 2026.  Berkeley have been aggressively buying back their shares but the share price has been above the stock's last-reported NAV so this isn't helping to grow official NAV. At this earnings multiple and with no discount to official NAV, I can't get away from a neutral stance.

Bodycote (LON:BOY) (£1.14bn)

Full year results

SP down 7%
Revenue remains under some pressure with a 2.9% organic decline or 1% growth excluding energy surcharges. "Core" adjusted operating profit grows by 2.9% to £128m.
PW: Challenging conditions. Current run-rate profit is broadly similar to H2 2024.

BLACK (AMBER) (Graham) [no section below]
This is now a little lower vs. when we looked at in November. A recovery in market conditions is taking longer than anticipated and profitability is standing still while the company goes about a restructuring programme that includes plant closures and operational performance improvements.
There is now a small net debt position (£68m) vs. net cash last year. It spent nearly £60m on buybacks in 2024 and continues to buy them back today, and I'm not sure that its shares are sufficiently cheap to justify this. I downgrade my stance to neutral to reflect today's disappointing guidance.

Target Healthcare Reit (LON:THRL) (£564m)

Half-year Report

Net tangible assets +1.8% to 112.7p (SP: 90.8p). “Growing rent roll and stable valuations”.

GREEN (Graham)
I like this category of real estate and the discount to NAV on offer here, even after the share price recently…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here